Experience in Transitioning from Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension. Parikh KS, Doerfler S, Shelburne N, Kennedy K, et al. J Cardiovasc Pharmacol 2020 Jan 13. doi: 10.1097/FJC.0000000000000800.

Read + Share

Amedeo Smart

Independent Medical Education

Parikh KS, Doerfler S, Shelburne N, Kennedy K, et al. Experience in Transitioning from Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension. J Cardiovasc Pharmacol 2020 Jan 13. doi: 10.1097/FJC.0000000000000800.
PMID: 31934912